Showing 36,681 - 36,700 results of 37,155 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 0.90s Refine Results
  1. 36681

    Risk of bias diagram and summary. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  2. 36682

    Forest plot of NT-pro BNP. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  3. 36683

    Funnel plot of 6-MWT. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  4. 36684

    Forest plot of LVEF. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  5. 36685

    Forest plot of 6-MWT. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  6. 36686

    The incidence rate of adverse events. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  7. 36687

    Basic characteristics of included studies. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  8. 36688

    Forest plot of LVESD. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  9. 36689

    Forest plot of clinical efficacy rate. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  10. 36690

    Data_Sheet_1_Endotoxemia-Induced Release of Pro-inflammatory Mediators Are Associated With Increased Glomerular Filtration Rate in Humans in vivo.DOCX by Remi Beunders (9604286)

    Published 2020
    “…Mean arterial pressure decreased with 13 ± 11 mmHg (p < 0.0001). No significant increase in the urinary excretion of tubular injury markers was observed following LPS administration. …”
  11. 36691
  12. 36692

    Insulin effects on taste cell type marker mRNA in taste organoids. by Shingo Takai (7853843)

    Published 2019
    “…Each score is expressed as mean + SEM. *P<0.05, **P<0.01, ***P<0.001, in post hoc Tukey HDS test.…”
  13. 36693

    Supplementary file 1_Tacrolimus exposure during the three-month period following allogeneic stem cell transplantation predicts overall survival.docx by Alzbeta Zavrelova (4885270)

    Published 2025
    “…These AUC<sub>tc</sub> values were independent variables for overall survival in multivariate analysis, with RR of 3.01 (P = 0.0056), 3.22 (P = 0.0058), and 2.93 (P = 0.0184) for the whole three-month period, second month, and third month of therapy, respectively. …”
  14. 36694

    Attenuation of IL-1β-induced MMP-3 mRNA expression in fibroblasts transfected with ATF-2 siRNA. by Nanako Kitanaka (3350285)

    Published 2019
    “…<p>(<b>a</b>) In the cells transfected with ATF-2 and scrambled siRNAs, t-ATF-2 and β-actin were detected by western blotting. …”
  15. 36695

    Fig 4 - by Laure Bridoux (481118)

    Published 2020
    “…One-way ANOVA with post-hoc Tukey HSD test: * = p<0.01; ** = p<0.001.</p>…”
  16. 36696

    Knockdown of <i>fhplk1</i> disrupts growth and cell proliferation in juvenile <i>Fasciola hepatica in vitro.</i> by Paul McCusker (634425)

    Published 2025
    “…<b>(D)</b> Confocal images of EdU staining (green) in four-week-old <i>F. hepatica</i> treated with <i>fhplk1</i> dsRNA <i>in vitro</i> shows reduction in # EdU<sup>+</sup> nuclei compared to control dsRNA treated worms; scale bar = 100 µm, DAPI counterstain (magenta). **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.</p>…”
  17. 36697

    DataSheet_1_Autonomous observations of biogenic N2 in the Eastern Tropical North Pacific using profiling floats equipped with gas tension devices.pdf by Craig L. McNeil (16304715)

    Published 2023
    “…At 17 °N preformed excess-N<sub>2</sub> decreased from approximately 28 to 12 µmol/kg over σ<sub>0 =</sub> 24–27 kg/m<sup>3</sup> with a resulting precision of ±1 µmol N<sub>2</sub>/kg; at 12 °N values were similar except in the potential density range of 25.7< σ<sub>0</sub>< 26.3 where they were lower by 1 µmol N<sub>2</sub>/kg due likely to being composed of different source waters. …”
  18. 36698

    Data_Sheet_1_Elevated Serum Inflammatory Markers in Subacute Stroke Are Associated With Clinical Outcome but Not Modified by Aerobic Fitness Training: Results of the Randomized Con... by Bernadette Kirzinger (11334015)

    Published 2021
    “…It is suggested that physical fitness training may play a role in decreasing long-term inflammatory activity and supports tissue recovery.…”
  19. 36699

    Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients i... by Yashika Chugh (7325960)

    Published 2019
    “…Compared to scenario I, scenario III leads to an increase in QALYs by 0.44 (0.14 to 1.01) per person, and is cost-neutral. …”
  20. 36700